
Sign up to save your podcasts
Or
More on dividend growth investing -> Join our market newsletter!
In today's episode, Greg dives into a practical application of our dividend growth strategy by discussing a recent buy, a watch, and a sell.
He starts the episode with Hershey (HSY), exploring why this classic chocolate maker made it into our portfolio despite soaring cocoa prices. Although it may sound like a boring name, companies like this can generate outsized long-term returns.
For the watch candidate, Greg turns his attention to CVS Health (CVS). Despite its financial strength and attractive valuation, he discusses CVS's coming headwinds. Sometimes when there is a lot of negative sentiment surrounding a company, there is potential to make a lot of money.
Lastly, Greg explains his decision to trim our position in Emerson Electric (EMR). Even though it is a long-time dividend growth stalwart and has seen strong price performance recently, it no longer meets our dividend growth criteria.
Send us a text
Schedule a meeting with us -> Financial Planning & Portfolio Management
If you submit a question to us and we use it in an episode, we will send you an official The Dividend Mailbox Yeti® Tumbler -> Email us at [email protected].
Notes & Resources:
DCM Investment Reports & Models
Visit our website to learn more about our investment strategy and wealth management services.
Follow us on:
Instagram - Facebook - LinkedIn - X
If you enjoy the show, we'd greatly appreciate it if you subscribe and leave a review
5
4141 ratings
More on dividend growth investing -> Join our market newsletter!
In today's episode, Greg dives into a practical application of our dividend growth strategy by discussing a recent buy, a watch, and a sell.
He starts the episode with Hershey (HSY), exploring why this classic chocolate maker made it into our portfolio despite soaring cocoa prices. Although it may sound like a boring name, companies like this can generate outsized long-term returns.
For the watch candidate, Greg turns his attention to CVS Health (CVS). Despite its financial strength and attractive valuation, he discusses CVS's coming headwinds. Sometimes when there is a lot of negative sentiment surrounding a company, there is potential to make a lot of money.
Lastly, Greg explains his decision to trim our position in Emerson Electric (EMR). Even though it is a long-time dividend growth stalwart and has seen strong price performance recently, it no longer meets our dividend growth criteria.
Send us a text
Schedule a meeting with us -> Financial Planning & Portfolio Management
If you submit a question to us and we use it in an episode, we will send you an official The Dividend Mailbox Yeti® Tumbler -> Email us at [email protected].
Notes & Resources:
DCM Investment Reports & Models
Visit our website to learn more about our investment strategy and wealth management services.
Follow us on:
Instagram - Facebook - LinkedIn - X
If you enjoy the show, we'd greatly appreciate it if you subscribe and leave a review
490 Listeners
3,178 Listeners
296 Listeners
64 Listeners
188 Listeners
880 Listeners
45 Listeners
38 Listeners
25 Listeners
78 Listeners
31 Listeners
40 Listeners
35 Listeners
7 Listeners
58 Listeners